Under the terms of the cash and stock deal, NewGenIVF is paying $750,000 in cash and issuing 125,000 ordinary shares at $34 ...
The first hemophilia B patient at the Loma Linda University Health Hemophilia Treatment Center to receive Hympavzi is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback